$XBI $94.36 | -2.98%
Covid Updates
$NVAX -4.1% Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial source
Pipeline Updates
$JAGX -9.4% Jaguar Health Completes Final Major Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea in Dogs source
$DNLI -5.4% Denali Therapeutics Announces Continued Progress in DNL310 (ETV:IDS) Program for MPS II (Hunter Syndrome) Supporting Planned Initiation of Phase 2/3 Clinical Trial source
$PHAS 0.0% PhaseBio Announces Bentracimab Phase 2b Trial Data Accepted for Late Breaking Clinical Research Presentation at the 2022 American College of Cardiology (ACC.22) Annual Scientific Session source
$URGN -5.0% UroGen Announces Data that Shows In-Office Nephrostomy Tube Administration of Jelmyto® is Efficient for Doctors and Well Tolerated by Patients source
$SCYX -1.2% SCYNEXIS Announces Positive Results from Its Pivotal Phase 3 CANDLE Study of Oral Ibrexafungerp for Prevention of Recurrent Vaginal Yeast Infections, Clearing the Way for Regulatory Submission and Potential Approval of Additional Indication by End of 2022 source
Business Updates
$OBSV -2.8% ObsEva Enters into Licensing Agreement with Theramex for the Commercialization of Linzagolix source
$VERA -6.6% Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock source
Posted by JM
Bình luận